Skip to Content
MilliporeSigma
Search Within
Document Type

112-86-7

Applied Filters:
Keyword:'112-86-7'
Showing 1-30 of 203 results for "112-86-7" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
91 6 36 93 71 108 112 88 85 68 51 74 76 104 96 98 89 PKA 2 91 35 17 94 95 105 106 96 66 97 91 104 104 96 96 70 99 87 PKCα
The Effective Use of Protein Kinase Inhibitors
91 6 36 93 71 108 112 88 85 68 51 74 76 104 96 98 89 PKA 2 91 35 17 94 95 105 106 96 66 97 91 104 104 96 96 70 99 87 PKCα
Product Information Sheet - A0772
Description Molecular Formula: C2H3OCl Molecular Weight: 78.50 CAS Number: 75-36-5 Melting Point: -112 °C1 Boiling Point: 52 °C1 Density: 1.104 g/ml1 Acetyl chloride is a commonly used acetylation
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 1 112 – 232 pg/mL IL-9 Control 1 111 – 231 pg/mL Control 2 559 – 1161 pg/mL Control 2 533 – 1107 pg/mL
Product Information Sheet - B1381
(1997) 7. Ignarro, L. J., Stimulation of Phagocytic Release of Neutral Protease from Human Neutrophils by Cholinergic Amines and Cyclic 3',5'-Guanosine Monophosphate. J. Immunol., 112(1), 210-214
Data Sheet - SRP5052
.25 mM DTT, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼86 kDa Purity: 70–95% (SDS-PAGE, see Figure 1) Specific Activity: 112–152 nmole/min/mg (see Figure 2) Precautions and Disclaimer
Data Sheet - H157
receptor antagonist, HOE 140, in isolated blood vessels from different species. Br. J. Pharmacol., 112, 683-689 (1994). Wirth, K., et al., Hoe 140, a new potent and long acting bradykinin antagonist:
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
117 19 18 9 1409 12 112 41 24 86 10 36 23 36 27 119 21 std 6 18 9 7273 15 123 41 25 87 13 40 23 34 26 124 21 18 11
User Guide-RAB0420
Plasma 112 83-137 Cell Culture Supernatants 94 86-102 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 104 78 94 Range (%) 95-110 70-86 85-99 1
User Guide-RAB0243
Range (%) Serum 105 96-112 Plasma 94 86-102 Cell Culture Media 97 90-105 Linearity Sample Type Serum Plasma Cell Culture Media 1:2 Average % of Expected 112 111 98 Range (%) 104-120
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
111 1 112 1 110 1 54 1 IPI00022463 Serotransferrin precursor 393 8 131 3 551 11 193 6 571 11 543 11 67 1 194 5 828 14 1051 19 IPI00022432 Transthyretin precursor 47 1 138 3
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
G-CSF Control 1 112 - 232 pg/mL IL-15 Control 1 93 - 193 pg/mL Control 2 561- 1165 pg/mL Control 2 484 - 1005 pg/mL
Application Note Anaerobic EM using ICR+
Recovery (%) Diameter of Colonies (mm) after 5 days after 7 days after 10 days C. sporogenes ATCC 19404 73/96/90 ∅ 86 76/97 101 7 – 10 N/A N/A C. sporogenes ATCC 11437 48/49/59 ∅ 52 56
Data Sheet - R8282
Z. et al., A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell, 112, 77-86, (2003). PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC. JB,JR,MAM 06/12-1
Periodic table A4
126.90 113.7 184.4 2.21 , 1, 3, 5, 7 54 131.29 –111.74 –108.09 Xe 2, 4, 6 [Kr] 4d105s25p6 *209.99 302 336.95 1.96 , 1, 3, 5, 7
Data Sheet - R8282 - Lot 040M0725
Z. et al., A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell, 112, 77-86, (2003). Precisio is a registered trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich
Data Sheet - R8282 - Lot 109K0790
Z. et al., A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell, 112, 77-86, (2003). Precisio is a trademark of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.
User Guide-RAB0083
. Mean recoveries are as follows: Sample Type Average % Recovery Range (%) Serum 86 77-95 Plasma 78 67-86 Cell Culture Supernatants 82 74-89 Linearity Sample Type Serum Plasma Cell Culture
User Guide-RAB1286
Plasma 128 112-147 Cell Culture Supernatants 99 68-147 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 100 94 76 Range (%) 94-106 84-99 67-86 1:4 Average
User Guide-RAB1929
Range (%) 101-114 91-107 92-98 1:4 Average % of Expected Range 105 97 108 Range (%) 99-111 86-105 104-112 4 RAB1929pis Rev 08/24 Reproducibility Intra-Assay CV%: <10% Inter-Assay
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
–1, 1, 3, 5, 7 [Xe] 4f145d106s26p5 86 *222.02 –71 –61.7 Rn 2 [Xe] 4f145d106s26p6 102.91 31 45 2 1966 4 3727 5 1.5 6
User Guide-RAB0236
Serum 86 73-94 Plasma 77 71-84 Cell Culture Supernatants 106 93-112 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 104 106 91 Range (%) 94-112 98-
User Guide-RAB0053
Range (%) 115-135 105-126 90-110 1:4 Average % of Expected Range 113 113 103 Range (%) 112-133 102-130 91-112 4 RAB0053pis Rev 08/24 Reproducibility Intra-Assay CV%: <10% Inter-
Periodic table Poster
1.76Po 2, 4, 6 [Xe] 4f145d106s26p4 85 *209.99 302 336.95 1.96At –1, 1, 3, 5, 7 [Xe] 4f145d106s26p5 86 *222.02 –71 –61.7 Rn 2 [Xe] 4f145d106s26p6 113 *284
User Guide-RAB0236
Serum 86 73-94 Plasma 77 71-84 Cell Culture Supernatants 106 93-112 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 104 106 91 Range (%) 94-112 98-
User Guide-RAB0094
106 93-112 Plasma 104 92-110 Cell Culture Supernatants 97 89-108 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 95 97 94 Range (%) 85-104 86-105 82
Product Information Sheet-RAB0197
Serum 97 86-105 Plasma 103 93-112 Cell Culture Supernatants 96 85-93 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 98 103 105 Range (%) 86-106 91
Product Information Sheet - L0881
Narcissus pseudonarcissus 26 2 (h) α-D-man Perseau americana − − − − Phaseolus coccineus 112 4 − − Phaseolus limensis 247(II) 8 A galNAc
User Guide-RAB0490
Cell Culture Supernatants 103 91-112 Linearity Sample Type Serum Plasma Cell Culture Supernatants 1:2 Average % of Expected 102 104 101 Range (%) 88-111 89-113 86-108 1:4 Average % of Expected
Page 1 of 7